Literature DB >> 9164979

Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation.

J L Riley1, R G Carroll, B L Levine, W Bernstein, D C St Louis, O S Weislow, C H June.   

Abstract

When HIV-infected leukocytes are activated by the CD28 costimulatory receptor, HIV-1 is rapidly cleared from cultures, suggesting that costimulation can render T cells resistant to HIV-1 infection. In this study we tested the hypothesis that enhanced secretion of cytokines or chemokines could account for CD28-induced antiviral effects. In an acute infection system, resistance to infection with macrophage-tropic strains of HIV-1 was shown to be comprised of both soluble and cell-associated components. Induction of HIV-1 resistance was specific for CD28 costimulation, in that a variety of other accessory receptors, such as CD2, CD4, CD5, and MHC class I, failed to confer the antiviral resistance. The soluble component was secreted by both CD4 and CD8 T cells, was not unique to CD28 costimulation, and could be neutralized by removal of C-C chemokines (RANTES (regulated upon activation, normal T cell expressed and secreted) and macrophage inflammatory protein-1alpha and -1beta) from the culture supernatants of costimulated CD4 T cells. In contrast, CD28 stimulation of CD4 cells resulted in the specific induction of a pronounced intrinsic resistance to HIV-1 infection by macrophage tropic isolates of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164979

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

Authors:  M Mengozzi; M Malipatlolla; S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.

Authors:  Becky Schweighardt; Ann-Marie Roy; Duncan A Meiklejohn; Edward J Grace; Walter J Moretto; Jonas J Heymann; Douglas F Nixon
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 3.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines.

Authors:  C H Herrmann; R G Carroll; P Wei; K A Jones; A P Rice
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Toward synthetic biology with engineered T cells: a long journey just begun.

Authors:  Carl H June
Journal:  Hum Gene Ther       Date:  2014-09       Impact factor: 5.695

6.  Baboon CD8 T cells suppress SIVmac infection in CD4 T cells through contact-dependent production of MIP-1α, MIP-1β, and RANTES.

Authors:  Veronica Obregon-Perko; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  Cytokine       Date:  2018-05-26       Impact factor: 3.861

7.  Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.

Authors:  D Bienzle; K S Macdonald; K F Copeland; J J Bwayo; F A Plummer; K L Rosenthal
Journal:  Can J Infect Dis       Date:  2000-09

8.  The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope.

Authors:  Luis M Agosto; Jianqing J Yu; Megan K Liszewski; Clifford Baytop; Nikolay Korokhov; Laurent M Humeau; Una O'Doherty
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

9.  Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.

Authors:  Atsushi Yoshida; Reiko Tanaka; Tsutomu Murakami; Yoshiaki Takahashi; Yoshio Koyanagi; Masataka Nakamura; Mamoru Ito; Naoki Yamamoto; Yuetsu Tanaka
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 10.  Adoptive immunotherapy for cancer or viruses.

Authors:  Marcela V Maus; Joseph A Fraietta; Bruce L Levine; Michael Kalos; Yangbing Zhao; Carl H June
Journal:  Annu Rev Immunol       Date:  2014-01-09       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.